adminの記事一覧

The Urinary Liver-Type Fatty Acid Binding Protein (L-FABP) in Early Detection and Outcome Prediction of Sepsis-Associated Acute Kidney Injury.

Arch Acad Emerg Med. 2025.doi: https://doi.org/10.22037/aaemj.v13i1.2525SBMU Journals

腎機能の低下による過剰ろ過の判断値　年齢を考慮した新たな数式を提唱

■━━━━━━━━━━━━━━━━━━━━━━━━■腎疾患診断用バイオマーカー L-FABP情報サイト■□■□メールマガジン□■□■No.70／2025年1月配信号［医療者向け］https://fabp.jp/?utm_source=mailmagazine&utm_campaign=250

Estimated Proximal Tubule Fluid Phosphate Concentration and Renal Tubular Damage Biomarkers in Early Stages of Chronic Kidney Disease.

J Ren Nutr. 2024.doi: 10.1053/j.jrn.2024.06.009.PubMed

Clustering based on renal and inflammatory admission parameters in critically ill patients admitted to the ICU.

PLoS One. 2024doi: 10.1371/journal.pone.0307938.PubMed

Topiroxostat-A Safer Uricostatic Drug with Enhanced Renal Protection: A Narrative Review.

J Assoc Physicians India. 2024doi: 10.59556/japi.72.0724.PubMed

Diagnostic Accuracy of L-FABP-to-Creatinine Ratio (LCR) for Prediction of Kidney Damage in Type-2 DM Patients Taking Albumin-to-Creatinine Ratio (ACR) as Gold Standard.

J Pak Soc Intern Med. 2024.doi: jpsim.v5i4.2465JPSIM

ISCCM Guidelines on Acute Kidney Injury and Renal Replacement Therapy.

Indian J Crit Care Med. 2022.doi: 10.5005/jp-journals-10071-24109.PubMed

L-FABP情報サイトがリニューアルオープンしました

■━━━━━━━━━━━━━━━━━━━━━━━━■腎疾患診断用バイオマーカー L-FABP情報サイト■□■□メールマガジン□■□■No.69／2024年11月配信号［医療者向け］https://fabp.jp/?utm_source=mailmagazine&utm_campaign=24

Development of Liver Fibrosis Represented by the Fibrosis-4 Index Is a Specific Risk Factor for Tubular Injury in Individuals with Type 2 Diabetes.

Biomedicines. 2024doi: 10.3390/biomedicines12081789.PubMed

尿細管マーカーの見方

臨床検査 68(4) 2024